雷傑納隆藥廠REGN
那斯達克 · USD
544.80
-0.66
(-0.12%)
盤中 08/02 02:26 (UTC+8)
08/02 02:26 (UTC+8)
雷傑納隆藥廠REGN
544.80
-0.66
(-0.12%)
財務數據
損益表
- 31.62
- 31.58
- 33.63
- 34.34
- 31.45
- 35.47
- 37.21
- 37.89
- 30.29
- 36.76
- -7.39
- -0.13
- 6.48
- 2.13
- -8.42
- 12.79
- 4.89
- 1.84
- -20.07
- 21.36
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | |
營業收入淨額 | 3,675,600 | 3,028,700 | 3,789,200 | 3,720,700 | 3,547,100 | 3,145,000 | 3,434,300 | 3,362,700 | 3,158,100 | 3,162,100 |
營業成本 | - | 464,300 | 565,400 | 491,100 | 480,200 | 433,800 | 517,000 | 436,400 | 404,900 | 457,500 |
營業毛利 | - | 2,564,400 | 3,223,800 | 3,229,600 | 3,066,900 | 2,711,200 | 2,917,300 | 2,926,300 | 2,753,200 | 2,704,600 |
營業費用 | - | - | 2,233,600 | - | - | 1,959,800 | 1,944,400 | 1,815,300 | 1,736,700 | 1,757,900 |
研發費用 | - | 1,327,400 | 1,412,100 | 1,271,500 | 1,200,000 | 1,248,400 | 1,177,200 | 1,075,300 | 1,085,300 | 1,101,200 |
推銷及管理費用 | - | 633,000 | 807,700 | 722,400 | 773,400 | 704,300 | 737,200 | 640,000 | 651,400 | 600,600 |
非經常性項目費用 | - | 12,300 | 13,800 | 56,200 | 23,900 | 7,100 | 30,000 | 100,000 | - | 56,100 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 1,079,500 | 591,700 | 990,200 | 1,179,500 | 1,069,600 | 751,400 | 972,900 | 1,111,000 | 1,016,500 | 946,700 |
其他收入及費用 | - | 322,000 | -21,600 | 327,300 | 573,300 | -34,600 | 193,000 | 17,600 | 85,300 | -70,700 |
利息費用 | - | 8,700 | 10,500 | 13,800 | 14,800 | 16,100 | 18,300 | 17,800 | 18,900 | 18,000 |
稅前純益 | 1,518,700 | 905,000 | 958,100 | 1,493,000 | 1,628,100 | 700,700 | 1,147,600 | 1,110,800 | 1,082,900 | 858,000 |
所得稅 | 127,100 | 96,300 | 40,400 | 152,400 | 195,800 | -21,300 | -12,000 | 103,000 | 114,500 | 40,200 |
稅後純益 | 1,391,600 | 808,700 | 917,700 | 1,340,600 | 1,432,300 | 722,000 | 1,159,600 | 1,007,800 | 968,400 | 817,800 |
基本每股稅後盈餘(元) | 13.24 | 7.58 | 8.53 | 12.40 | 13.25 | 6.70 | 10.88 | 9.48 | 9.05 | 7.64 |
稀釋每股稅後盈餘(元) | 12.81 | 7.27 | 8.11 | 11.55 | 12.41 | 6.27 | 10.20 | 8.89 | 8.51 | 7.17 |
基本平均股數(千股) | 105100.00 | 106700.00 | 107600.00 | 108100.00 | 108100.00 | 107800.00 | 106600.00 | 106300.00 | 107000.00 | 107100.00 |
稀釋平均股數(千股) | 108600.00 | 111200.00 | 113800.00 | 116200.00 | 115400.00 | 115100.00 | 113800.00 | 113400.00 | 113900.00 | 114000.00 |
還原基本每股稅後盈餘(元) | 13.24 | 7.58 | 8.53 | 12.40 | 13.25 | 6.70 | 10.88 | 9.48 | 9.05 | 7.64 |
還原稀釋每股稅後盈餘(元) | 12.81 | 7.27 | 8.11 | 11.55 | 12.41 | 6.27 | 10.20 | 8.89 | 8.51 | 7.17 |
還原基本平均股數(千股) | 105,100 | 106,700 | 107,600 | 108,100 | 108,100 | 107,800 | 106,600 | 106,300 | 107,000 | 107,100 |
還原稀釋平均股數(千股) | 108,600 | 111,200 | 113,800 | 116,200 | 115,400 | 115,100 | 113,800 | 113,400 | 113,900 | 114,000 |
EBITDA(千元) | 1,518,700 | 1,040,600 | 1,095,000 | 1,628,500 | 1,763,600 | 830,900 | 1,278,900 | 1,234,000 | 1,204,900 | 975,500 |